GLP-1 · AustraliaWegovy vs Rybelsus Australia:
Weekly Injection or Daily Tablet?
The short answer: Wegovy is a weekly injection. Rybelsus is a daily tablet. Both contain semaglutide, but they are entirely different products, approved for different purposes, at very different price points.
Quick comparison: July 2026
Wegovy
Weekly injection
Weight management
$269–$460/month private
Rybelsus
Daily tablet
Type 2 diabetes only
PBS co-payment (T2D)
There is no Wegovy tablet currently available in Australia. The oral semaglutide product that does exist here is Rybelsus, approved only for Type 2 diabetes.
Already taking one of these medicines?
Keep your prescribed dose, reminders, eScript and remaining repeats organised in one place.
30-day trial · Then $4.99/month or $39.99/year
MediRemind tracks your injection or tablet schedule, current prescribed dose and remaining repeats.
Published July 2026 · Fact-checked against TGA, PBS.gov.au and PBAC recommendation
Searching for "Wegovy pill" or "Wegovy tablet"?
There is no Wegovy tablet available in Australia. An oral version was approved in the US in December 2025. It is not TGA-approved here and has no confirmed Australian launch date. The oral semaglutide that does exist in Australia is called Rybelsus, and it is approved only for Type 2 diabetes, not weight management.
What is semaglutide?
Semaglutide is a GLP-1 receptor agonist, a type of medication that mimics the GLP-1 hormone, which regulates blood sugar and appetite. Novo Nordisk, the Danish pharmaceutical company, manufactures both Wegovy and Rybelsus using semaglutide as the active ingredient. Despite sharing the same active ingredient, the two products are absorbed differently, use different doses and have different approved indications. Rybelsus is registered in Australia as an oral semaglutide medicine.
Wegovy, the weekly injection for weight management
Wegovy is semaglutide in a prefilled auto-injector pen for subcutaneous injection. An injection just under the skin, typically into the abdomen, thigh or upper arm.
Keep every stage of your Wegovy schedule clear
Track your weekly injection day, prescribed dose stage, repeats and next prescription date.
30-day trial · Then $4.99/month or $39.99/year
Rybelsus, the daily tablet for Type 2 diabetes
Rybelsus is an oral GLP-1 medicine registered in Australia for Type 2 diabetes, not for weight management.
Important reminders on iPhone
With permission enabled, MediRemind can use Apple Critical Alerts so selected medication reminders can come through even when the iPhone is on Silent or Focus mode. Useful for the Rybelsus 30-minute window or a Wegovy injection day.
MediRemind is a medication management tool, not a registered medical device. Reminders, including Critical Alerts on supported iPhones, depend on device settings, user permissions and connectivity. MediRemind does not replace professional medical advice or your own awareness of your medication schedule.
Make the 30-minute morning window easier to follow
Set your reminder before breakfast and keep your prescribed dose and repeats organised.
30-day trial · Then $4.99/month or $39.99/year
Head-to-head comparison
| Wegovy | Rybelsus | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Form | Weekly injection pen | Daily tablet |
| TGA approved use | Weight management + cardiovascular risk reduction | Type 2 diabetes only |
| PBS listed | Not yet (PBAC recommended late 2025; negotiations continuing) | Yes, for Type 2 diabetes |
| Starting dose | 0.25 mg weekly | 3 mg daily |
| Maintenance dose | 2.4 mg weekly | 14 mg daily |
| Food restrictions | No | Yes, empty stomach, 30 min before food |
| Storage | Refrigerate before first use | Room temperature |
| Monthly cost (approx.) | $269–$460 private prescription | PBS co-payment for T2D |
No-cost tool
Build My Treatment Schedule
Tell us which medicine you take. We'll show you a personalised schedule you can save directly in MediRemind.
Which medicine are you currently taking?
PBS Waitlist
When Wegovy gets PBS-listed, the price drops by up to 90%
Enter your email and we'll send you one notification the moment a PBS listing date is confirmed, nothing else.
No spam. One email when Wegovy gets PBS-listed. Unsubscribe any time.
Is there a Wegovy pill available in Australia?
An oral version of Wegovy was approved in the United States in December 2025. It is not currently TGA-approved or available as Wegovy tablets in Australia. There is no confirmed Australian launch date.
Australians searching for 'Wegovy pill' or 'Wegovy tablet' are likely responding to news of the US approval, oral Wegovy launched commercially in the United States in January 2026, which is what is driving the searches. Until an oral Wegovy form is registered here by the TGA, it cannot be legally prescribed or sold in Australia. For the latest on any TGA submission or Australian timeline, check TGA.gov.au.
The oral semaglutide product that is available in Australia is Rybelsus, which is registered for Type 2 diabetes, not weight management, as described above.
Wegovy Oral Tablet: Australia Waitlist
Want the Wegovy pill?
Get notified when it's approved in Australia.
The oral Wegovy tablet was approved in the US in December 2025. It is not yet TGA-approved or available in Australia. We're watching the TGA register, one email when that changes.
No spam. One email when Wegovy oral tablets are TGA-approved in Australia. Unsubscribe any time.
Already on the Wegovy injection? Track your schedule in MediRemind
Can I use Rybelsus for weight loss?
Rybelsus does cause weight reduction, studies in people with Type 2 diabetes showed reductions in body weight as a secondary effect. However, it is not approved or PBS-listed in Australia for weight management.
Australian doctors can legally prescribe any TGA-approved medicine off-label. That is, for a purpose other than its approved indication. If a doctor prescribes Rybelsus for weight management, you would pay the full private price, not the PBS co-payment, because the subsidy applies only to the approved Type 2 diabetes indication.
Wegovy was specifically studied and approved for chronic weight management. Rybelsus is approved in Australia for Type 2 diabetes and should not be regarded as an interchangeable tablet version of injectable Wegovy.
If weight management is your goal, speak to your doctor about which treatment is appropriate for your circumstances.
PBS Waitlist
Get notified when Wegovy's PBS price is confirmed
The difference between private and PBS cost can be hundreds of dollars a month. We'll email you the moment the listing goes live, one email, no spam.
No spam. One email when Wegovy gets PBS-listed. Unsubscribe any time.
Managing your treatment: Wegovy or Rybelsus
Both Wegovy and Rybelsus are long-term treatments. Both require you to stay on top of your schedule, your current dose stage, your repeats and your next prescription, for months or years.
If you are on Wegovy, MediRemind helps you:
- Set a weekly injection reminder on the same day each week
- Track your current dose stage and escalation schedule
- See how many repeats remain on your current script
- Get a reminder when it is time to arrange your next prescription
- Store your eScript safely, no searching through old SMS messages
- Manage Wegovy alongside any other medications without a pharmacy login
If you are on Rybelsus, MediRemind helps you:
- Set a daily morning reminder early enough to take the tablet before breakfast, with time to wait the full 30 minutes
- Track your dose stage (3 mg → 7 mg → 14 mg) and when your doctor plans to review
- Monitor repeats remaining and refill timing
- Store your eScript in one place
MediRemind
Weekly injection or daily tablet, keep the whole schedule in one place
Organise your prescribed dose, reminders, eScript and remaining repeats without being tied to one pharmacy.
Keep My Treatment Schedule Organised30-day trial · Then $4.99/month or $39.99/year · iPhone and Android
This article is for general information only and does not constitute medical or pharmaceutical advice. Information about PBS listings, TGA approvals and medication pricing is accurate at the time of writing and subject to change, verify current status at PBS.gov.au or TGA.gov.au before relying on it. Speak to your doctor or pharmacist before making any decisions about your medication or treatment. MediRemind is not affiliated with Novo Nordisk or any other pharmaceutical manufacturer.
References to weight management medications on this page are for general information only. MediRemind does not prescribe, supply or endorse any specific medication. Individual circumstances vary, speak to your doctor about which treatment is appropriate for you.